Sophie Bellanger

873 total citations
22 papers, 691 citations indexed

About

Sophie Bellanger is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Sophie Bellanger has authored 22 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Sophie Bellanger's work include Cervical Cancer and HPV Research (7 papers), Cancer-related Molecular Pathways (6 papers) and Skin Protection and Aging (4 papers). Sophie Bellanger is often cited by papers focused on Cervical Cancer and HPV Research (7 papers), Cancer-related Molecular Pathways (6 papers) and Skin Protection and Aging (4 papers). Sophie Bellanger collaborates with scholars based in Singapore, France and United States. Sophie Bellanger's co-authors include Françoise Thierry, Chye Ling Tan, Stéphanie Blachon, Caroline Demeret, Chen Huei Leo, Wen Long Nei, Armand de Gramont, Joëlle Sobczak‐Thépot, Francisca Méchali and John E. Oblong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Sophie Bellanger

19 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Bellanger Singapore 14 324 262 139 123 112 22 691
Cara L. Benjamin United States 11 164 0.5× 191 0.7× 198 1.4× 94 0.8× 49 0.4× 25 582
Naoko Taguchi‐Atarashi Japan 8 319 1.0× 216 0.8× 49 0.4× 218 1.8× 38 0.3× 11 689
Cecília J. de Almeida United States 9 261 0.8× 170 0.6× 18 0.1× 76 0.6× 58 0.5× 10 557
Shi Liu China 17 323 1.0× 351 1.3× 50 0.4× 250 2.0× 64 0.6× 35 791
Živa Frangež Switzerland 9 190 0.6× 190 0.7× 59 0.4× 199 1.6× 22 0.2× 11 510
Ada Yukht United States 14 174 0.5× 400 1.5× 26 0.2× 239 1.9× 86 0.8× 17 667
Caroline Cheung Japan 18 462 1.4× 138 0.5× 158 1.1× 186 1.5× 89 0.8× 27 877
Tina Seremet Denmark 16 204 0.6× 236 0.9× 278 2.0× 529 4.3× 33 0.3× 30 1.0k
Luigi Tortola Switzerland 14 328 1.0× 109 0.4× 141 1.0× 612 5.0× 40 0.4× 30 966
Ulrich König Austria 9 225 0.7× 153 0.6× 45 0.3× 70 0.6× 78 0.7× 11 460

Countries citing papers authored by Sophie Bellanger

Since Specialization
Citations

This map shows the geographic impact of Sophie Bellanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Bellanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Bellanger more than expected).

Fields of papers citing papers by Sophie Bellanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Bellanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Bellanger. The network helps show where Sophie Bellanger may publish in the future.

Co-authorship network of co-authors of Sophie Bellanger

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Bellanger. A scholar is included among the top collaborators of Sophie Bellanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Bellanger. Sophie Bellanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bois, E., et al.. (2025). Supraglottoplasty outcomes and peri-operative care in congenital laryngomalacia. European Archives of Oto-Rhino-Laryngology. 282(4). 1971–1980.
2.
Ramasamy, Adaikalavan, et al.. (2024). Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes. Biochemical Pharmacology. 229. 116507–116507. 1 indexed citations
3.
Teissier, N., et al.. (2024). Nap polysomnography in infants with laryngomalacia as a tool to predict treatment strategy. European Archives of Oto-Rhino-Laryngology. 281(6). 3107–3113.
5.
Bellanger, Sophie, et al.. (2023). Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals. 16(4). 504–504. 51 indexed citations
6.
Jarrold, Bradley B., Chin Yee Ho, TuKiet T. Lam, et al.. (2022). Early onset of senescence and imbalanced epidermal homeostasis across the decades in photoexposed human skin: Fingerprints of inflammaging. Experimental Dermatology. 31(11). 1748–1760. 18 indexed citations
7.
Li, Jia, Takeshi Uemura, J. Hardman, et al.. (2021). The Polyamine Regulator AMD1 Upregulates Spermine Levels to Drive Epidermal Differentiation. Journal of Investigative Dermatology. 141(9). 2178–2188.e6. 5 indexed citations
8.
Tan, Chye Ling, et al.. (2021). Nicotinamide Prevents UVB- and Oxidative Stress‒Induced Photoaging in Human Primary Keratinocytes. Journal of Investigative Dermatology. 142(6). 1670–1681.e12. 41 indexed citations
9.
Tan, Chye Ling, et al.. (2019). Nicotinamide Metabolism Modulates the Proliferation/Differentiation Balance and Senescence of Human Primary Keratinocytes. Journal of Investigative Dermatology. 139(8). 1638–1647.e3. 45 indexed citations
10.
Robinson, Kim S., et al.. (2018). Dual Role of the Anaphase Promoting Complex/Cyclosome in Regulating Stemness and Differentiation in Human Primary Keratinocytes. Journal of Investigative Dermatology. 138(8). 1851–1861. 15 indexed citations
11.
Tan, Chye Ling, et al.. (2015). Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy. Cell Cycle. 14(9). 1459–1470. 13 indexed citations
12.
Lai, Deborah, Chye Ling Tan, Jayantha Gunaratne, et al.. (2013). Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism. PLoS ONE. 8(9). e75625–e75625. 67 indexed citations
13.
Tan, Chye Ling, Jayantha Gunaratne, Deborah Lai, et al.. (2012). HPV-18 E2^E4 chimera: 2 new spliced transcripts and proteins induced by keratinocyte differentiation. Virology. 429(1). 47–56. 9 indexed citations
14.
Bellanger, Sophie, et al.. (2011). Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.. American Journal of Cancer Research. 1(3). 373–389. 45 indexed citations
15.
Bellanger, Sophie, Chye Ling Tan, Wen Long Nei, Ping He, & Françoise Thierry. (2009). The Human Papillomavirus Type 18 E2 Protein Is a Cell Cycle-Dependent Target of the SCF Skp2 Ubiquitin Ligase. Journal of Virology. 84(1). 437–444. 32 indexed citations
16.
Bellanger, Sophie, Armand de Gramont, & Joëlle Sobczak‐Thépot. (2007). Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2. Oncogene. 26(51). 7175–7184. 44 indexed citations
17.
Dufresne, S, et al.. (2006). [Group therapy versus individual follow-up in the management of the obese child].. PubMed. 13 Suppl 1. S62–6.
18.
Bellanger, Sophie, et al.. (2005). High-Risk But Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability. Cell Cycle. 4(11). 1608–1615. 70 indexed citations
19.
Blachon, Stéphanie, Sophie Bellanger, Caroline Demeret, & Françoise Thierry. (2005). Nucleo-cytoplasmic Shuttling of High Risk Human Papillomavirus E2 Proteins Induces Apoptosis. Journal of Biological Chemistry. 280(43). 36088–36098. 64 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026